WALTHAM, Massachusetts, November 21, 2017 /PRNewswire/ --
EarlySense, the market leader in contact-free continuous
"On the heels of our recent accelerated market traction, we are excited to welcome Karissa as our COO to help meet the growing demand for our monitoring and data solutions across the continuum of care," said Halperin. "Karissa's broad healthcare experience and deep home care knowledge will be instrumental in our ongoing efforts to empower medical teams to save lives and enable consumers to achieve better health, while enhancing patient safety and improving outcomes."
Dr. Price earned her Ph.D. in International Political Economy from Harvard University and has held a variety of healthcare positions over the past 20 years. She previously served as President of Healthways (NASDAQ: HWAY), a well-being and wellness provider for employers, health plans and health systems. She also brings experience in remote patient care, having served as CMO of Intel-GE Care Innovations, a joint venture that connected the care continuum to the home. Prior to that, Dr. Price was the co-founder and CEO of The Trusted Hands Network, a referral service that matched people in need of home care with certified home care agencies across the United States.
"EarlySense is well regarded as a technology innovator that helps facilitate improved patient safety and outcomes while enabling providers to do more with less through empowering clinicians and consumers," said Dr. Price. "Contact-free continuous monitoring provides tremendous clinical, economic and psychological benefits for medical professionals, patients and families while not requiring patients to do anything they are not already doing - lying in bed or sitting in a chair- a true innovation in the monitoring space. I look forward to working with Avner, the EarlySense team, and our partners and clients to bring the company's solutions to even more people across the globe and to help people live their best lives."
EarlySense® provides contact-free, continuous monitoring solutions for the medical and consumer digital health markets. EarlySense's FDA-cleared systems utilize Artificial Intelligence (AI) and big data analytics to provide actionable health insights and improve clinical outcomes.
Used worldwide in hospitals, rehab and skilled nursing facilities, EarlySense assists clinicians in early detection of patient deterioration, helping to prevent adverse events, including code blues which are a result of cardiac or respiratory arrest, preventable ICU transfers, patient falls and pressure ulcers.
EarlySense offers clinically-proven technology to consumers with EarlySense® Live™ and Percept™. EarlySense® Live™ is the first at-home consumer health monitor powered by EarlySense's medically-proven sensor and AI analytics. Live is particularly useful for tracking the health and sleep of the aging population and children, to help facilitate better health choices. EarlySense® Percept™ is the first clinically-proven monitor for fertility and period tracking. It accurately tracks internal body signals and assists couples who are trying to conceive.
EarlySense has partnered with leading global technology companies including Samsung, Welch Allyn, iFit and Beurer. The company is based in Ramat Gan, Israel and Waltham, MA.
For more information, visit http://www.earlysense.com, http://www.earlysense.com/live and http://www.earlysense.com/percept.
Follow EarlySense on LinkedIn, Twitter and Facebook, EarlySense Live on Facebook and Twitter and Percept at Facebook, Instagram, and Twitter.
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All